financetom
Business
financetom
/
Business
/
Amgen drug leads to up to 20% weight loss in trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amgen drug leads to up to 20% weight loss in trial
Nov 26, 2024 4:36 AM

Nov 26 (Reuters) - Amgen's ( AMGN ) experimental drug

MariTide led to average weight loss of up to 20% in a year-long

mid-stage trial of nearly 600 people who were overweight or

obese, the company said on Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ryde Group Renews Operating License in Singapore for Another 3 Years, Shares Racing Higher
Ryde Group Renews Operating License in Singapore for Another 3 Years, Shares Racing Higher
Dec 26, 2024
10:14 AM EST, 12/26/2024 (MT Newswires) -- Ryde Group ( RYDE ) rallied Thursday, with shares of the mobility services company recently climbing almost 66%, after saying municipal officials in Singapore have renewed its license as a full ride-hailing and carpool operator for the next three years. Trading volume for Ryde Group ( RYDE ) shares also was significantly higher...
Looking At Red Cat Hldgs's Recent Unusual Options Activity
Looking At Red Cat Hldgs's Recent Unusual Options Activity
Dec 26, 2024
High-rolling investors have positioned themselves bearish on Red Cat Hldgs ( RCAT ) , and it's important for retail traders to take note. This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in RCAT often signals that someone has privileged information. Today,...
OptiNose to Implement 1-for-15 Reverse Stock Split
OptiNose to Implement 1-for-15 Reverse Stock Split
Dec 26, 2024
10:05 AM EST, 12/26/2024 (MT Newswires) -- OptiNose ( OPTN ) said Thursday it will implement a 1-for-15 reverse stock split, effective Monday. The company said its common stock will start trading on Nasdaq on a split-adjusted basis on Tuesday. The reverse split is intended to enable the company to regain compliance with Nasdaq's $1 minimum closing bid price rule...
SEALSQ Launches SEALQUANTUM.com Lab To Help Businesses Transition To Quantum-Safe Encryption
SEALSQ Launches SEALQUANTUM.com Lab To Help Businesses Transition To Quantum-Safe Encryption
Dec 26, 2024
On Thursday, SEALSQ Corp ( LAES ) announced the launch of SEALQUANTUM.com Lab, a research hub designed to help businesses transition to quantum-safe encryption. This initiative addresses the growing cybersecurity challenges posed by emerging quantum technologies, as traditional encryption methods become increasingly vulnerable to quantum computing advances. The SEALQUANTUM.com Lab aims to equip industries with the tools, knowledge, and resources...
Copyright 2023-2026 - www.financetom.com All Rights Reserved